The applicability of pericardial fluid in cardiac biomarkers dosing for post-mortem diagnosis of acute myocardial infarction. RevSALUS [Internet]. 6 de Abril de 2022 [citado 29 de Abril de 2026];4(Sup):196. Disponível em: https://revsalus.com/index.php/RevSALUS/article/view/431